Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Denali Therapeutics Inc (NQ: DNLI )

51.03 USD +0.04 (+0.08%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 30, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 563,818
Open 50.79
Bid (Size) 50.50 (20)
Ask (Size) 51.99 (2)
Prev. Close 50.99
Today's Range 50.75 - 53.04
52wk Range 22.75 - 93.94
Shares Outstanding 121,192,210
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Denali Therapeutics Announces Positive Interim Data from Phase 1/2 Study with ETV:IDS (DNL310) in Patients with the Lysosomal Storage Disease Hunter Syndrome (MPS II)
From GlobeNewswire News Releases
Denali Therapeutics to Present Interim Data from Phase 1/2 Study of ETV:IDS (DNL310) for the Potential Treatment of Hunter Syndrome at MPS 2021
Management to host webinar for analysts and investors on July 25th 
From GlobeNewswire News Releases

Performance

YTD
-27.98%
-27.98%
1 Month
-34.94%
-34.94%
3 Month
-15.57%
-15.57%
6 Month
-25.50%
-25.50%
1 Year
+112.80%
+112.80%

More News

Read More
Denali Therapeutics Announces Initiation of Phase 2 Study by Partner Sanofi of RIPK1-Inhibitor DNL758 (SAR443122) in Cutaneous Lupus Erythematosus (CLE) Patients
From GlobeNewswire News Releases
Dr. Stephen Hahn, 24th US FDA Commissioner and Former Chief Medical Executive at MD Anderson, joins Flagship Pioneering as Chief Medical Officer of Flagship's Preemptive Medicine and Health Security I
From PR Newswire
Senda Biosciences Announces Closing of $98 Million Series B Financing
From PR Newswire
Denali Therapeutics Moves Up In Market Cap Rank, Passing Unum Group
Tags Stocks
From Market News Video
Invaio Sciences Raises $88.9 Million to Accelerate the Transition to Biological Agriculture
From PR Newswire
12 Health Care Stocks Moving In Monday's Pre-Market Session
Tags ATIP ITRM NURO
From Benzinga
Denali's Brain-Penetrant Enzyme Therapy Shows Durable Effect With CNS Impact In Hunter Syndrome
Tags Briefs News General
From Benzinga
Why Denali Therapeutics Stock Is Sinking Today
Tags DNLI Market News
From Motley Fool
First Week of DNLI March 2022 Options Trading
Tags Stocks
From Market News Video
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.